Aberdeen Group
PBH icon

Aberdeen Group’s Prestige Consumer Healthcare PBH Stock Holding History

Aberdeen Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-290,170
Closed -$8.81M – 911
2018
Q4 		$8.81M Sell
290,170
-804,737
-73% -$29.4M 0.02% 468
2018
Q3 		$41.5M Buy
1,094,907
+65,155
+6% +$2.46M 0.08% 242
2018
Q2 		$39.5M Sell
1,029,752
-197,052
-16% -$6.64M 0.08% 246
2018
Q1 		$41.4M Sell
1,226,804
-57,683
-4% -$2.21M 0.08% 233
2017
Q4 		$57M Buy
1,284,487
+203,809
+19% +$9.28M 0.11% 182
2017
Q3 		$54.1M Buy
+1,080,678
New +$55.2M 0.1% 197

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Aberdeen Group's PBH Position: Q1 2019 in Review

Aberdeen Group sold out of Prestige Consumer Healthcare (PBH) in Q1 2019, closing a stake of 290,170 shares — an estimated $8.81M sold.

Aberdeen Group first reported a position in PBH in Q3 2017 and held it in 6 quarters. The position peaked at $57M in Q4 2017. 221 funds tracked by Wall St. Rank hold PBH as of Q1 2019.

  • Aberdeen Group reported no remaining Prestige Consumer Healthcare position as of Q1 2019 after selling out during the quarter.
  • Aberdeen Group sold 290,170 Prestige Consumer Healthcare shares in Q1 2019, an estimated $8.81M.
  • Aberdeen Group first reported a position in Prestige Consumer Healthcare in Q3 2017 and held it in 6 quarters.
  • Aberdeen Group's Prestige Consumer Healthcare position peaked at $57M in Q4 2017.
  • 221 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2019.

Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.